crispr
technolog
knock
target
gene
use
rnaguid
nucleas
also
activ
express
nucleasedefici
employ
use
latter
function
show
effect
crisprmedi
pinpoint
activ
endogen
express
also
known
tetherin
viru
restrict
factor
broad
antivir
spectrum
singleguid
rna
sgrna
sequenc
target
promot
select
promot
assay
potenti
sgrna
fuse
transactiv
domain
along
accessori
transcript
activ
complex
introduc
cell
lentivir
transduct
increas
express
mrna
transduc
cell
confirm
realtim
rtpcr
cell
express
highli
enhanc
show
effect
inhibit
product
replic
even
presenc
viral
antagonist
vpu
find
confirm
physiolog
stoichiometri
host
restrict
factor
viral
antagonist
may
determin
outcom
battl
virus
mid
requir
socal
accessori
auxiliari
hiv
protein
sthat
long
known
nonessenti
viral
replic
vitro
cultur
report
depend
celltyp
use
infect
experi
sinc
celltypedepend
requir
accessori
protein
explain
discoveri
hiv
restrict
factor
present
celltyp
depend
manner
find
indic
hiv
replic
cell
express
specif
restrict
factor
achiev
use
viral
accessori
protein
counteract
evad
inhibitori
activ
oneonon
confront
vif
versu
protein
vpu
versu
refer
hereaft
vpx
versu
nef
versu
transmembran
protein
potent
act
tether
hiv
particl
present
surfac
virusproduc
cell
restrict
factor
peculiar
unlik
three
factor
specif
inhibit
retrovir
infect
display
broadspectrum
activ
varieti
envelop
virus
well
retrovirus
eg
marburg
viru
lassa
viru
ebola
viru
sendai
viru
influenza
viru
herp
simplex
viru
kaposi
sarcomaassoci
herpesviru
vesicular
stomat
viru
chikungunya
viru
sar
corona
viru
hepat
b
viru
hepat
c
viru
human
parainfluenza
viru
almost
harbor
differ
viral
antagonist
suggest
import
counteract
restrict
factor
effici
viral
replic
sever
vivo
studi
impli
stoichiometr
balanc
restrict
factor
viral
antagonist
might
determin
diseas
progress
target
enhanc
endogen
express
may
provid
new
therapeut
strategi
although
use
typei
interferon
ifn
may
benefici
enhanc
express
restrict
factor
includ
may
desir
specif
upregul
target
gene
express
order
avoid
ifnassoci
advers
effect
vivo
studi
employ
newli
establish
molecular
method
use
catalyt
inact
version
cluster
regularli
interspac
short
palindrom
repeat
crispr
associ
protein
base
rnaguid
activ
system
modifi
system
allow
us
specif
target
activ
endogen
promot
gene
interest
nucleasedefici
mutant
bind
singl
guid
rna
sgrna
recruit
transcript
factor
complex
es
use
system
herein
attempt
enhanc
endogen
express
observ
whether
crisprbas
pinpoint
activ
express
abl
confer
cell
inhibitori
activ
virion
product
even
presenc
viral
antagonist
vpu
counteract
bind
downregul
restrict
factor
crisprbas
rnaguid
activ
system
sgrna
target
nucleotid
addit
pam
sequenc
ngg
locat
within
base
pair
transcript
start
site
promot
dispers
promot
region
select
six
differ
sgrna
target
promot
fig
identifi
best
sgrna
target
sequenc
promot
clone
promot
firefli
luciferas
report
plasmid
cotransfect
hela
cell
promoterind
plasmid
togeth
plasmid
express
sgrna
append
phage
rna
stem
loop
loop
well
fuse
herp
simplex
viru
transcript
factor
minim
activ
domain
term
transcript
factor
fusion
protein
nfkb
transactiv
subunit
activ
domain
human
heatshock
factor
fuse
phage
coat
protein
perform
luciferas
assay
promot
activ
system
use
six
sgrna
target
among
reveal
activ
fig
therefor
select
two
sgrna
target
sequenc
experi
examin
whether
sgrna
inde
abl
activ
endogen
express
employ
lentivir
vector
system
transduct
first
produc
lentivirus
express
fusion
protein
cell
next
infect
ho
cell
lentivirus
select
transduc
cell
blasticidin
whose
resist
gene
express
use
vector
next
produc
anoth
lentiviru
express
transcript
factor
fusion
protein
transduc
blasticidinselect
cell
viral
vector
select
cell
use
hygromycin
lastli
gener
lentiviru
express
andor
transduc
dualli
select
ho
cell
viral
vector
select
cell
zeocin
perform
western
analysi
success
confirm
activ
express
endogen
protein
polyclon
popul
crisprtransduc
ho
cell
although
addit
effect
two
sgrna
observ
fig
clone
transduc
cell
use
limit
dilut
subject
result
singl
cell
clone
realtim
rtpcr
flow
cytometri
immunofluoresc
realtim
rtpcr
show
endogen
express
mrna
drastic
activ
singl
cell
clone
fig
cellsurfac
express
analyz
flow
cytometri
robustli
increas
clone
cell
fig
addit
immunofluoresc
reveal
high
level
intracellular
express
cell
fig
conclud
crisprbas
system
effect
activ
express
next
perform
infectionbas
viru
product
assay
hela
cell
crisprmodifi
ho
cell
well
control
ho
cell
infect
either
vpuintact
defici
vsvgpseudotyp
virus
prepar
cell
transfect
correspond
plasmid
virus
produc
infect
hela
ho
cell
subject
elisa
determin
level
viru
product
wwwnaturecomscientificreport
wwwnaturecomscientificreport
fig
product
vpu
mutant
virus
also
vpuintact
virus
effect
inhibit
singl
clone
cell
fig
importantli
electron
microscop
analys
show
vpuintact
virus
inde
accumul
surfac
posit
ho
cell
fig
final
transduc
tcell
line
exhibit
intermedi
level
express
use
lentivir
crispr
system
enhanc
endogen
express
protein
realtim
rt
pcr
show
crisprtransduc
clonal
cell
inde
express
high
level
mrna
fig
without
affect
cell
prolifer
fig
perform
viral
replic
assay
use
either
wildtyp
hiv
vpudefect
virus
consist
result
obtain
product
assay
replic
vpu
mutant
also
wildtyp
virus
markedli
decreas
posit
cell
fig
therefor
conclud
enhanc
endogen
express
lead
inhibit
product
well
multipleround
replic
even
presenc
antagonist
vpu
studi
first
identifi
sgrna
target
sequenc
promot
region
activ
express
transduc
cell
lentivirus
express
sgrna
plu
togeth
accessori
transcript
activ
induc
enhanc
express
mrna
protein
level
result
success
inhibit
viral
product
replic
mani
case
host
restrict
factor
abl
inhibit
hiv
infect
normal
counteract
hiv
accessori
protein
act
viral
antagonist
howev
shown
outcom
battl
host
restrict
factor
viral
antagonist
may
determin
intrins
activ
also
stoichiometr
balanc
sinc
overexpress
wwwnaturecomscientificreport
wwwnaturecomscientificreport
restrict
factor
reliev
blockad
impos
viral
antagonist
also
suggest
sever
studi
show
level
express
restrict
factor
link
diseas
progress
viral
infect
word
even
presenc
virusencod
antagonist
host
restrict
factor
express
higher
chanc
inactiv
virus
although
typei
ifn
upregul
hundr
ifnstimul
gene
includ
mani
host
restrict
factor
studi
sivinfect
rhesu
macaqu
show
treatment
effect
vivo
acut
phase
infect
rather
detriment
chronic
stage
due
enhanc
system
inflamm
even
human
studi
typei
ifn
report
upregul
provid
target
cell
potenti
lead
loss
tcell
sens
like
pinpoint
activ
restrict
factor
without
use
ifn
might
benefici
host
inde
present
studi
show
endogen
express
enhanc
crispr
method
led
remark
decreas
product
multipleround
replic
harbor
viral
antagonist
vpu
although
case
gene
activ
inhibitori
effect
wildtyp
infect
weak
higher
express
implic
growth
progress
cancer
due
abil
promot
cellto
cell
interact
activ
nfkbmediat
signal
transduct
pathway
case
may
better
avoid
tradit
overexpress
system
use
exogen
transgen
lead
uncontrol
robust
express
target
protein
crispr
activ
result
endogen
maxim
level
express
reflect
natur
mechan
action
physiolog
relev
phenotyp
vivo
also
instead
lentivir
system
use
studi
adenoassoci
viral
vector
appli
futur
experi
readili
prepar
hightit
viru
stock
transduc
primari
cell
moreov
may
necessari
achiev
specif
gene
deliveri
crisprbas
vector
infect
cell
target
restrict
factor
enhanc
endogen
express
may
provid
new
therapeut
strategi
combat
hiv
infect
use
system
pursu
possibl
crisprbas
activ
antivir
protein
especi
case
could
one
novel
therapeut
strategi
inhibit
infect
prevent
transmiss
well
varieti
envelop
virus
dna
construct
luciferasereport
promot
construct
creat
pcramplifi
promot
sequenc
switchgear
genom
librari
use
dna
extract
ho
cell
clone
nheixhoidigest
fragment
promega
lentivir
plasmid
lenti
express
fuse
transactiv
domain
lenti
sgrna
zeo
backbon
express
sgrna
link
bacteriophag
coat
proteinbind
stem
loop
lenti
express
fuse
nfkb
transactiv
subunit
activ
domain
human
heatshock
factor
obtain
f
zhang
massachusett
institut
technolog
addgen
plasmid
id
respect
base
onlin
tool
chopchop
detect
number
mismatch
specif
sgrna
target
sequenc
promot
select
within
base
pair
transcript
start
site
previous
map
avoid
potenti
offtarget
site
two
mismatch
note
crisprmedi
control
promot
activ
highli
sensit
even
singl
wwwnaturecomscientificreport
wwwnaturecomscientificreport
mismatch
probabl
due
narrow
window
target
sequenc
six
differ
oligonucleotid
encod
select
sgrna
individu
insert
lenti
sgrna
zeo
backbon
digest
bsmbi
gener
lentivir
sgrna
express
plasmid
lentivir
packag
vector
vesicular
stomat
viru
gglycoprotein
vsvg
express
plasmid
pcvsvg
rev
express
plasmid
pcarev
tat
express
plasmid
pltrtat
provir
construct
envelop
glycoprotein
env
defici
provir
construct
pnle
envvpudefici
construct
pnle
u
pcagg
mammalian
express
plasmid
previous
describ
elsewher
replicationcompet
vpudefici
construct
pnlu
creat
introduc
hpai
site
vpu
initi
codon
use
quikchang
sitedirect
mutagenesi
stratagen
cell
mainten
hela
ho
cell
maintain
dmem
life
technolog
supplement
heatinactiv
fb
sigma
human
tcell
maintain
rpmi
life
technolog
supplement
heatinactiv
fb
promot
assay
hela
cell
cotransfect
triplic
plate
ng
lenti
lenti
ng
either
empti
vector
control
use
transfect
reagent
promega
accord
manufactur
instruct
h
cell
lyse
oneglo
luciferas
assay
reagent
promega
firefli
luciferas
activ
determin
centro
berthold
luminomet
crispr
lentivir
transduct
cell
cotransfect
ng
pcvsvg
either
lenti
lenti
use
transfect
reagent
promega
accord
manufactur
instruct
h
supernat
treat
u
ml
dnase
roch
appli
scienc
min
harvest
amount
antigen
measur
use
captur
enzymelink
immunosorb
assay
elisa
kit
xpressbio
ho
cell
cell
lowli
express
transduc
ng
lentiviru
lentiviru
h
transduc
cell
cultur
presenc
blasticidin
ml
life
technolog
hygromycin
ml
thermo
fisher
select
day
cell
stabli
express
togeth
transduc
lentiviru
express
empti
sgrna
sgrna
promot
transduc
cell
design
respect
select
zeocin
ml
invivogen
anoth
day
result
stabl
cell
subsequ
clone
limit
dilut
immunoblot
assay
cell
lyse
lysi
buffer
mm
tri
ph
mm
nacl
mm
edta
complet
proteas
inhibitor
mixtur
roch
appli
scienc
cell
extract
subject
gel
electrophoresi
transfer
nitrocellulos
membran
membran
probe
mous
polyclon
antibodi
abnova
react
protein
visual
chemiluminesc
use
ecl
western
blot
detect
system
ge
healthcar
monitor
use
imag
system
fujifilm
flow
cytometri
hela
ho
cell
incub
polyclon
antibodi
follow
stain
min
ice
antirabbit
igg
conjug
alexa
molecular
probe
cell
wash
extens
pb
plu
fb
fix
formaldehyd
pb
cell
analyz
flow
cytometri
use
bd
fac
canto
ii
data
collect
analyz
bd
fac
diva
softwar
immunofluoresc
microscopi
hela
ho
cell
collagenco
plate
glass
coverslip
cultur
h
fixat
fix
cell
permeabil
saponin
min
immunostain
polyclon
antibodi
secondari
antirabbit
igg
conjug
alexa
molecular
probe
use
ml
dna
stain
hoechst
molecular
probe
perform
ml
immunofluoresc
imag
observ
use
fluoview
olympu
virion
product
assay
transmiss
electron
microscopi
cell
cotransfect
provir
construct
pnle
pnle
u
togeth
ng
pcvsvg
empti
pcagg
use
fugen
h
supernat
harvest
subject
captur
elisa
crisprtransduc
ho
cell
seed
cell
infect
ng
vsvgpseudotyp
sixteen
hour
later
cell
wash
pb
ml
fresh
complet
medium
ad
virion
product
assay
supernat
harvest
h
subject
wwwnaturecomscientificreport
wwwnaturecomscientificreport
captur
elisa
transmiss
electron
microscopi
infect
cell
harvest
h
cell
scraper
wash
twice
icecold
pb
cell
prefix
glutaraldehyd
paraformaldehyd
phosphat
buffer
ph
h
room
temperatur
postfix
osmium
tetroxid
embed
epon
taab
laboratori
ultrathin
section
stain
uranyl
acet
lead
citrat
observ
transmiss
electron
microscop
hitachi
kv
replic
assay
cell
cotransfect
provir
construct
pnlu
use
fugen
h
supernat
harvest
subject
captur
elisa
cell
infect
h
either
wildtyp
vpudefect
virus
ng
antigen
wash
extens
serumfre
medium
cultur
fresh
complet
medium
supernat
sampl
everi
antigen
product
quantifi
use
elisa
valu
present
mean
sd
three
four
independ
experi
determin
basi
pilot
experi
estim
effect
number
statist
comparison
made
use
pair
twotail
student
ttest
p
consid
statist
signific
